Loading...

Skip Navigation LinksHome > Support Groups > Resources
Cancers :
Chronic Myeloid Leukemia / Chronic Myelocytic Leukemia

Chronic myeloid leukemia is a kind of cancer which causes an uncontrolled growth of the myeloid cells in the bone marrow and their crowding in blood. This kind of leukemia is called ‘chronic’ because it progresses slowly, and there are few early symptoms. But if the disease is caught early and appropriate treatment started, the prognosis is good.

Learn more by joining our online group on chronic myeloid leukemia.

 

Join this Group


 

New Insights into Acute Myeloid Leukemia Treatment
Rapid drug response screening for leukemia stem cells offers clues to relapse and to improving patient-specific therapies, revealed research.

.....
New drug combination for treating Chronic Leukemia
Combination of ibrutinib plus rituximab was found superior to the old treatment for patients aged below 70 years with chronic lymphocytic leukemia (CL.....
FDA's Nod for New Drug to Treat Acute Myeloid Leukemia
Xospata, the new drug, has been approved recently by the US Food and Drug Administration (FDA) for treating adults with relapsed or refractory acute m.....
Good Response Rate for Venetoclax Against AML
Venetoclax with azacitidine combination shown 91 percent response rate among older adults who were newly diagnosed with acute myeloid leukemia (AML), .....
New Strategy Identified to Treat Chemo-Resistant Acute Myeloid Leukemia
A promising strategy to treat chemotherapy-resistant acute myeloid leukemia has been developed by a team of researchers from The Ottawa Hospital and t.....


Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone marrow... Read More



Member Sign In

Remember me
Forgot Password?
Sign up now


Medwonders has 227695 Members and 444 Groups.
Last Updated - Dec 14, 2018 - Designed & Content Managed by Medindia4u.com Pvt. Ltd.
Copyright © 2018 Medindia4u.com Pvt. Ltd. All rights reserved.